Transforming growth factor-β1 expression in early biopsy specimen predicts long-term graft function following pediatric renal transplantation

The main cause of late graft loss or declining long‐term graft function is chronic allograft nephropathy (CAN), characterized by progressive interstitial fibrosis. Transforming growth factor (TGF)‐β1 plays a key role in fibrogenesis. We immunohistochemically investigated whether the degree of TGF‐β1...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical transplantation 2001-06, Vol.15 (3), p.185-191
Hauptverfasser: Ishimura, Takeshi, Fujisawa, Masato, Isotani, Shuji, Higuchi, Akihiro, Iijima, Kazumoto, Arakawa, Soichi, Hohenfellner, Katharina, Flanders, Kathleen C, Yoshikawa, Norishige, Kamidono, Sadao
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The main cause of late graft loss or declining long‐term graft function is chronic allograft nephropathy (CAN), characterized by progressive interstitial fibrosis. Transforming growth factor (TGF)‐β1 plays a key role in fibrogenesis. We immunohistochemically investigated whether the degree of TGF‐β1 expression in early biopsy specimens routinely obtained from stable allografts at 100 d could predict fibrosis and graft dysfunction in the late phase. Patients were children with grafts from related donors. We immunohistochemically determined intracellular and extracellular expression of TGF‐β1 in the graft using LC antibody (LC) for intracellular TGF‐β1 and CC antibody (CC) for extracellular TGF‐β1. The change in creatinine clearance between 100 d and 3 yr after transplantation (ΔCcr) was used as an index of long‐term graft function. We also used image analysis to calculate the relative area involved by interstitial fibrosis in the trichrome‐stained section of graft biopsy specimens at 100 d and 3 yr, designating the change as ΔFI. ΔCcr was −4.2±9.4 mL/min in subjects with minimal early immunoreactivity for CC and −20.5±15.9 mL/min in subjects with strong reactivity (p
ISSN:0902-0063
1399-0012
DOI:10.1034/j.1399-0012.2001.150307.x